Abstract:Objective To study the approach of targeting expression of suicide gene HSV-TK driven by human telomerase catalytic subunit (hTERT) promoter in lung cancer cells, and to investigate inhibitory effect of HSV-TK/GCV driven by hTERT promoter on proliferation of lung cancer cell line A549 in vitro and in vivo. Methods (1) Recombinant expression vectors of HSV-TiC driven by hTERT promoter and SV40 promoter (pGL3hTp-TK and pGL3-5V40-TK) were transfected into telomerase-positive human lung adenocarcinoma cell A549 and telomerase-negative human embryonic lung fibroblast cell MRC-5. The mRNA expression of TK gene was detected with RT-PCR method; (2) With the treatment of GCV, the proliferation of above transfected cells was investigated by MTT assay; Influence of GCV on apoptosis and cell cycle of these cells was evaluated with flow cytometry; (3) After the subcutaneously transplantation of A549 cells into nude mice, intra-tumor injection of plasmid-liposome as well as intra-peritoneal injection of GCV were performed to study anti-tumor effects of pGL3-hTp-TK/GCV and pGL3-SV40-TK/GCV in vivo. Results (1) Enzyme digestion and PCR suggested that recombinant plasmids of pGL3-hTp-TX and pGL3-SV40-TK were successfully constructed; TK mRNA expression was detected in both A549 and MRC-5 cells transfected with pGL3-SV40-TK, also in A549 transfected with pGhZ-hTp-TK, but not in MRC-5 transfected with pGL3-hTp-TK; (2) GCV showed significant inhibition effect on proliferation of A549 and MRC-5 transfected with pGL3-SV40-TK in vitro, also on that of A549 transfected with pGL3-hTp-TK, but not of MRC-5 transfected with pGLZ-hTp-TK;With the treatment of GCV, apoptosis index (AI) of A549 cells transfected with pGLZ-SV40-TK and pGL3-hTp-TK (21. 58%and 23. 19% respectively) increased significantly, compared with that of A549 transfected with pGL3-hTp and blank control; GCV enhanced the effects on AI in MRC-5 transfected with pGL3-SV40-TK(9.35%), but not with pGL3-hTp-TK(0.88%); (3) Inhibition ratio of pGL3-SV40-TK/GCV and pGL3-hTp-TK/GCV to transplanted tumor of A549 in nude mice (46.7% and 40.5% respectively) were significantly higher than that of negative control groups (9.7%, 14.3%, 7.0% and 8.0% respectively). Conclusion TK gene driven by hTERT promoter could express selectively in lung cancer cell. Lung cancer cell could be specifically inhibited by HSV-TK/GCV driven by hTERT promoter in vitro and in vivo.

HSVTK Gene Therapy for Carcinoembryonic Antigen-Producing Human Lung Cancer Cells

Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells

An Experimental Study on Targeting Suicide Gene Therapy for Lung Cancer with HSV-TK Driven by hTERT Promoter

Adenovirus-Mediated Hsv-Tk Gene Therapy Using Htert Promoter in Cne Cells in Vitro

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Esophageal Squamous Cancers.

Study on the Effect of Human CMV Early Transcriptional Enhancer on Human CEA Promoter

Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus-Thymidine Kinase/ganciclovir Direct Intratumoral Gene Therapy of Hepatocellular Carcinoma

Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy

Hsv-Tk/Gcv Gene Therapy Mediated By Ebv-Lmpi For Ebv-Associated Cancer

Transcription Activity of Ectogenic Human Carcinoembryonic Antigen Promoter in Lung Adenocarcinoma Cells A549.

HSV-tk/GCV Gene Therapy Mediated by EBV-LMP1 for EBV-associated Cancer

A Study on Selective Killing Effect of Hsv-tk/GCV Driven by Human Telomerase Catalytic Subunit Promoter on Human Lung Cancer Cell A549

4:10 PM Abstract No. 50 Intratumoral Radiofrequency Hyperthermia-Enhanced Herpes Simplex Virus Thymidine Kinase (HSV-TK) Gene Therapy of Orthotopic Lung Cancer Through the Augmentation of Apoptosis and Heat Shock Protein (HSP70) Expression Pathway

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach

Hypoxia-responsive Elements Enhancing the Toxicity of HSVtk-mediated Gene-Directed Enzyme Prodrug Therapy in Lung Cancer Cells Induced by Hypoxia

Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.

Hypoxia/radiation dual-sensitive promoters enhance the toxicity of HSVtk-mediated gene-directed enzyme prodrug therapy in Lung Cancer Cells

Recombinant AAV-mediated HSVtk Gene Transfer with Direct Intratumoral Injections and Tet-On Regulation for Implanted Human Breast Cancer.

Liposome-mediated HSV-TK Gene in the Treatment of Human Bladder Carcinoma

Tumor-specific transcriptional targeting of suicide gene therapy